{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"58"}],"title":"COVID medication"},{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"22"}],"title":"COVID hospitalization"},{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"13"}],"title":"COVID ICU stay"},{"measurements":[{"groupId":"OG000","value":"235"},{"groupId":"OG001","value":"192"}],"title":"No COVID infection reported"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"310"},{"groupId":"OG001","value":"285"}],"units":"Participants"}],"description":"In claims data COVID hospital admissions were defined as: claim type is \"HOSP\" or \"Institutional\" or location display contains \"inpatient\" with COVID diagnosis or COVID procedure or COVID medication in the same medical episode. In survey data, participants were asked to self-report COVID hospitalizations.","groups":[{"description":"Participants in this group will complete the baseline study activities, as described above. Additionally, participants will be instructed to create a Cue Health account and download the Cue Health App. Using the app and the 10 Cue Health COVID-19 molecular tests that are provided (or Cue Health Flu+COVID molecular tests if available and FDA authorized), the participant will perform tests after exposure or if symptoms arise. Participants can also use the test for close contacts who are exposed to COVID-19 and/or have symptoms. If COVID-19 infection occurs, participants will have access to telemedicine to discuss further with a healthcare professional. When clinically indicated, medication for the treatment of COVID-19 (and/or Influenza in case of Cue Health Flu+COVID test availability) will be prescribed and delivered to the participants' delivery address. Participants can also seek care through other healthcare providers or not seek care, at their discretion.","id":"OG000","title":"Intervention Arm"},{"description":"Participants in the control group will complete the baseline study activities, as described above. If symptoms arise or COVID-19 infection occurs, participants will test and seek care as they normally would.","id":"OG001","title":"Control Arm"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"During study participation (on average 12 months)","title":"Number of Participants With Hospitalizations Including COVID Medications","type":"PRIMARY","unitOfMeasure":"Participants"}